These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 9043756)

  • 1. Tubal ligation and the risk of ovarian carcinoma.
    Cornelison TL; Natarajan N; Piver MS; Mettlin CJ
    Cancer Detect Prev; 1997; 21(1):1-6. PubMed ID: 9043756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of tubal ligation on the incidence of epithelial cancer of the ovary.
    Koch M; Starreveld AA; Hill GB; Jenkins H
    Cancer Detect Prev; 1984; 7(4):241-5. PubMed ID: 6488215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for ovarian cancer in central Italy.
    Greggi S; Parazzini F; Paratore MP; Chatenoud L; Legge F; Mancuso S; La Vecchia C
    Gynecol Oncol; 2000 Oct; 79(1):50-4. PubMed ID: 11006030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tubal ligation and risk of breast cancer.
    Brinton LA; Gammon MD; Coates RJ; Hoover RN
    Br J Cancer; 2000 May; 82(9):1600-4. PubMed ID: 10789731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations.
    McGuire V; Felberg A; Mills M; Ostrow KL; DiCioccio R; John EM; West DW; Whittemore AS
    Am J Epidemiol; 2004 Oct; 160(7):613-8. PubMed ID: 15383404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
    Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
    Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives.
    Rosenblatt KA; Thomas DB
    Cancer Epidemiol Biomarkers Prev; 1996 Nov; 5(11):933-5. PubMed ID: 8922304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones.
    Harlow BL; Weiss NS; Roth GJ; Chu J; Daling JR
    Cancer Res; 1988 Oct; 48(20):5849-52. PubMed ID: 3167840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk.
    Tworoger SS; Fairfield KM; Colditz GA; Rosner BA; Hankinson SE
    Am J Epidemiol; 2007 Oct; 166(8):894-901. PubMed ID: 17656616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of pregnancy and the risk of epithelial ovarian cancer.
    Whiteman DC; Siskind V; Purdie DM; Green AC
    Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):42-6. PubMed ID: 12540502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tubal ligation and survival of ovarian cancer patients.
    Zhang M; Holman CD
    J Obstet Gynaecol Res; 2012 Jan; 38(1):40-7. PubMed ID: 22070411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthropometry and the risk of epithelial ovarian cancer.
    Greer JB; Modugno F; Ness RB; Allen GO
    Cancer; 2006 May; 106(10):2247-57. PubMed ID: 16596653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.
    Riman T; Nilsson S; Persson IR
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):783-95. PubMed ID: 15315588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tubal sterilization and risk of cancer of the endometrium.
    Lacey JV; Brinton LA; Mortel R; Berman ML; Wilbanks GD; Twiggs LB; Barrett RJ
    Gynecol Oncol; 2000 Dec; 79(3):482-4. PubMed ID: 11104624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer.
    Bushley AW; Ferrell R; McDuffie K; Terada KY; Carney ME; Thompson PJ; Wilkens LR; Tung KH; Ness RB; Goodman MT
    Gynecol Oncol; 2004 Dec; 95(3):672-9. PubMed ID: 15581980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic inflammatory disease and the risk of epithelial ovarian cancer.
    Risch HA; Howe GR
    Cancer Epidemiol Biomarkers Prev; 1995; 4(5):447-51. PubMed ID: 7549798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marital and reproductive experience in a community-wide epidemiological study of breast cancer.
    Lilienfeld AM; Coombs J; Bross ID; Chamberlain A
    Johns Hopkins Med J; 1975 Apr; 136(4):157-62. PubMed ID: 1123861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based case-control study of ovarian cancer in Shanghai.
    Shu XO; Brinton LA; Gao YT; Yuan JM
    Cancer Res; 1989 Jul; 49(13):3670-4. PubMed ID: 2731180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancer.
    Greer JB; Modugno F; Allen GO; Ness RB
    Obstet Gynecol; 2005 Apr; 105(4):731-40. PubMed ID: 15802398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.